Free shipping on all orders over $ 500

GSK2256294A

Cat. No. M14423

All AbMole products are for research use only, cannot be used for human consumption.

GSK2256294A Structure
Synonym:

GSK 2256294

Price and Availability

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

GSK2256294A is a potent, reversible, tight binding inhibitor of isolated recombinant human sEH (soluble epoxide hydrolase) (IC50 = 27 pM; t1/2 = 121 min) and displays potent inhibition against the rat (IC50 = 61 pM) and murine (IC50 = 189 pM) orthologs of sEH. IC50 value: 27 pM Target: sEH in vitro: GSK2256294A also displays potent cellular inhibition (IC50 = 0.66 nM) of sEH in an assay developed using a cell line transfected with the human sEH enzyme. in vivo: A novel, potent, selective inhibitor of recombinant human, rat and mouse sEH, GSK2256294A, exhibits potent cell-based activity, a concentration-dependent inhibition of the conversion of 14,15-EET to 14,15-DHET in human, rat and mouse whole blood, and a dose-dependent increase in the LTX/LTX diol ratio in rat plasma following oral administration. Mice receiving 10 days of cigarette smoke exposure concomitant with oral administration of GSK2256294A exhibits significant, dose-dependent reductions in pulmonary leukocytes and keratinocyte chemoattractant levels. Mice receiving oral administration of GSK2256294A following 10 days of cigarette smoke exposure exhibited significant reductions in pulmonary leukocytes compared to vehicle-treated mice.

Chemical Information
Molecular Weight 447.46
CAS Number 1142090-23-0
Solubility (25°C) DMSO ≥ 47 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Patricia L Podolin, et al. In vitro and in vivo characterization of a novel soluble epoxide hydrolase inhibitor

[2] Steffen Brunst, et al. Designing a Small Fluorescent Inhibitor to Investigate Soluble Epoxide Hydrolase Engagement in Living Cells

Related Epoxide Hydrolase Products
Pentyl Chloroformate

Certain substituted caprolactam carbonates and ethers, compound compositions containing them and their use in the study of tumors.

TPPU

TPPU is a potent soluble epoxide hydrolase inhibitor; orally bioavailable and brain penetrant.

AUDA

AUDA is a potent inhibitor of soluble epoxide hydrolase (sEH) with IC50 of 18 nM and 69 nM for the mouse sEH and human sEH, respectively. AUDA has anti-inflammatory activity that reduces the protein expression of MMP-9, IL-1β, TNF-α and TGF-β.

Valpromide

Valpromide (VPD) is a derivative of valproic acid (VPA) and is used as an antiepileptic drug.

EC5026

EC5026 (BPN-19186) is a first-in-class, potent and orally active soluble inhibitor of Epoxide Hydrolase (sEH). EC5026 has the potential to relieve pain by stabilizing natural analgesic and anti-inflammatory mediators.

  Catalog
Abmole Inhibitor Catalog




Keywords: GSK2256294A, GSK 2256294 supplier, Epoxide Hydrolase, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.